Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Hartford Post.
Press releases published on May 27, 2025
Mystic Museum of Art and Mashantucket Pequot Museum and Research Center Present Gifts of the Ocean (Kutha Makooôkanash)
EIN Presswire
·
May 27, 2025
Gifts of the Ocean presents the historical wealth of Pequot culture, its near erasure by colonial conquest, and its vibrant contemporary expression. MYSTIC, CT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Mystic Museum of Art (MMoA) and The …
Washington Agency’s Tony Gioia and Joanne Donne Honored with Main Street America Award for Excellence in Real Estate
EIN Presswire
·
May 27, 2025
HARWINTON, CT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- The Washington Agency, co-led by industry veterans Tony Gioia and Joanne Donne, has received the 2025 Main Street America Award for Excellence in Real Estate, a national honor presented in …
Compass Diversified Takes Action to Improve its Financial Position in Response to Investigation into Lugano Holding, Inc.
GlobeNewswire
·
May 27, 2025
Entered into Forbearance Agreement with Lender Group Reduced Management Fees Suspended Quarterly Distribution on Common Shares Received Notice of Late Filing from NYSE WESTPORT, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“ …
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
GlobeNewswire
·
May 27, 2025
DSMB recommended the continuation of trial as planned Topline data expected in Q3 2025 NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop …
BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
GlobeNewswire
·
May 27, 2025
NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that the Nasdaq Hearings Panel …